# Ionis Pharmaceuticals Inc. – FDA Inspection, Sep 29, 2023

Source: https://www.keypedia.com/records/fda_inspections/ionis-pharmaceuticals-inc/da06818c-0f2a-4964-be45-5000ce2d99e7
Source feed: FDA_Inspections

> FDA inspection 1221199 of Ionis Pharmaceuticals Inc., September 29, 2023. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221199
- Company Name: Ionis Pharmaceuticals Inc.
- Inspection Date: 2023-09-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1304626 - 2026-01-15](https://www.keypedia.com/records/fda_inspections/ionis-pharmaceuticals-inc/fede8502-3eb4-44d5-853b-e9446bc1ac9d)
- FDA Inspection 1144090 - 2021-05-20
- FDA Inspection 1075511 - 2018-03-02
- FDA Inspection 953293 - 2015-10-29
- FDA Inspection 808370 - 2012-11-09

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/andrea-a-branche/9ffe9b53-7963-49a6-be4e-25e644f1759f)

Company: https://www.keypedia.com/companies/ionis-pharmaceuticals-inc/9eb29168-333f-432b-9620-f87f413dedc7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c